Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Predicting the future in immunoglobulin A nephropathy: a new international risk prediction tool.

Barbour SJ, Feehally J.

Nephrol Dial Transplant. 2019 Sep 24. pii: gfz181. doi: 10.1093/ndt/gfz181. [Epub ahead of print] No abstract available.

PMID:
31550359
2.

Glomerular Filtration Rate-Specific Cutoffs Can Refine the Prognostic Value of Circulating Cardiac Biomarkers in Advanced Chronic Kidney Disease.

Canney M, Tang M, Er L, Barbour SJ, Djurdjev O, Levin A; CanPREDDICT Investigators.

Can J Cardiol. 2019 Sep;35(9):1106-1113. doi: 10.1016/j.cjca.2019.06.014. Epub 2019 Jun 21.

PMID:
31472810
3.

Validation of Self-Reported Race in a Canadian Provincial Renal Administrative Database.

Waheed A, Djurdjev O, Dong J, Gill J, Barbour S.

Can J Kidney Health Dis. 2019 Jul 1;6:2054358119859528. doi: 10.1177/2054358119859528. eCollection 2019.

4.

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.

Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, Jefferson JA, Gipson PE, Rizk DV, Sedor JR, Simon JF, McCarthy ET, Brenchley P, Sethi S, Avila-Casado C, Beanlands H, Lieske JC, Philibert D, Li T, Thomas LF, Green DF, Juncos LA, Beara-Lasic L, Blumenthal SS, Sussman AN, Erickson SB, Hladunewich M, Canetta PA, Hebert LA, Leung N, Radhakrishnan J, Reich HN, Parikh SV, Gipson DS, Lee DK, da Costa BR, Jüni P, Cattran DC; MENTOR Investigators.

N Engl J Med. 2019 Jul 4;381(1):36-46. doi: 10.1056/NEJMoa1814427.

PMID:
31269364
5.

A propensity score matched analysis shows no adverse effect of early steroid withdrawal in non-diabetic kidney transplant recipients with and without glomerulonephritis.

Barbour S, Djurdjev O, Gill JS, Dong JJ, Gill J.

Kidney Int. 2019 Aug;96(2):460-469. doi: 10.1016/j.kint.2019.02.041. Epub 2019 Apr 1.

PMID:
31248649
6.

Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease.

Carter SA, Lightstone L, Cattran D, Bagga A, Barbour SJ, Barratt J, Boletis J, Caster D, Coppo R, Fervenza FC, Floege J, Hladunewich M, Hogan JJ, Kitching AR, Lafayette R, Malvar A, Radhakrishnan J, Rovin BH, Zhang H, Gutman T, Howell M, Logeman C, Shen JI, Teixeira-Pinto A, Alexander SI, Cho Y, Craig JC, Harris D, Johnson DW, Kerr PG, Ryan J, Viecelli AK, Wang AY, Wilkie M, Scholes-Robertson N, Tong A; SONG-GD Initiative.

Kidney Int. 2019 Jun;95(6):1280-1283. doi: 10.1016/j.kint.2019.01.047. No abstract available.

PMID:
31122702
7.

Disease-specific incident glomerulonephritis displays geographic clustering in under-serviced rural areas of British Columbia, Canada.

Canney M, Induruwage D, McCandless LC, Reich HN, Barbour SJ.

Kidney Int. 2019 Aug;96(2):421-428. doi: 10.1016/j.kint.2019.02.032. Epub 2019 Mar 15.

PMID:
31113679
8.

Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.

Barbour SJ, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Katafuchi R, Er L, Espino-Hernandez G, Kim SJ, Reich HN, Feehally J, Cattran DC; International IgA Nephropathy Network.

JAMA Intern Med. 2019 Jul 1;179(7):942-952. doi: 10.1001/jamainternmed.2019.0600. Erratum in: JAMA Intern Med. 2019 Jul 1;179(7):1007.

PMID:
30980653
9.

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Floege J, Barbour SJ, Cattran DC, Hogan JJ, Nachman PH, Tang SCW, Wetzels JFM, Cheung M, Wheeler DC, Winkelmayer WC, Rovin BH; Conference Participants.

Kidney Int. 2019 Feb;95(2):268-280. doi: 10.1016/j.kint.2018.10.018.

10.

Central nervous system laboratory-confirmed influenza meningo-encephalitis treated with peramivir.

Fox J, Barbour S, Junco SJ.

Int J Antimicrob Agents. 2018 Oct;52(4):517-518. doi: 10.1016/j.ijantimicag.2018.06.020. Epub 2018 Jul 7. No abstract available.

PMID:
30318059
11.

Primary membranous nephropathy presenting with crescentic glomerulonephritis 25 years after initial presentation: A case report
.

Massicotte-Azarniouch D, Barbour S, Blanco P, Clark EG.

Clin Nephrol. 2018 Oct;90(4):291-295. doi: 10.5414/CN109428.

PMID:
29932409
12.

C-terminal truncation of IFN-γ inhibits proinflammatory macrophage responses and is deficient in autoimmune disease.

Dufour A, Bellac CL, Eckhard U, Solis N, Klein T, Kappelhoff R, Fortelny N, Jobin P, Rozmus J, Mark J, Pavlidis P, Dive V, Barbour SJ, Overall CM.

Nat Commun. 2018 Jun 20;9(1):2416. doi: 10.1038/s41467-018-04717-4.

13.

Hemoglobin state-flux: A finite-state model representation of the hemoglobin signal for evaluation of the resting state and the influence of disease.

Barbour RL, Graber HL, Barbour SS.

PLoS One. 2018 Jun 8;13(6):e0198210. doi: 10.1371/journal.pone.0198210. eCollection 2018.

14.

Assessing the fate of explosives derived nitrate in mine waste rock dumps using the stable isotopes of oxygen and nitrogen.

Hendry MJ, Wassenaar LI, Barbour SL, Schabert MS, Birkham TK, Fedec T, Schmeling EE.

Sci Total Environ. 2018 Nov 1;640-641:127-137. doi: 10.1016/j.scitotenv.2018.05.275. Epub 2018 May 30.

PMID:
29859430
15.

The Economic Problem of Candidacy.

Barbour SE.

Psychoanal Rev. 2018 Jun;105(3):329-352. doi: 10.1521/prev.2018.105.3.329. Review.

PMID:
29791264
16.

The BC Glomerulonephritis Network: Improving Access and Reducing the Cost of Immunosuppressive Treatments for Glomerular Diseases.

Barbour S, Lo C, Espino-Hernandez G, Gill J, Levin A.

Can J Kidney Health Dis. 2018 Mar 20;5:2054358118759551. doi: 10.1177/2054358118759551. eCollection 2018.

17.

An update on predicting renal progression in IgA nephropathy.

Barbour S, Reich H.

Curr Opin Nephrol Hypertens. 2018 May;27(3):214-220. doi: 10.1097/MNH.0000000000000405. Review.

PMID:
29432215
18.

Incidence of skeletal related events in patients with bone metastasis receiving denosumab every four weeks compared to intervals greater than every four weeks.

Yerram P, Moore R, Wolf S, Barbour SY.

J Oncol Pharm Pract. 2019 Apr;25(3):529-534. doi: 10.1177/1078155217743074. Epub 2017 Dec 5.

PMID:
29207934
19.

Species differences and mechanism of action of A3 adenosine receptor allosteric modulators.

Du L, Gao ZG, Paoletta S, Wan TC, Gizewski ET, Barbour S, van Veldhoven JPD, IJzerman AP, Jacobson KA, Auchampach JA.

Purinergic Signal. 2018 Mar;14(1):59-71. doi: 10.1007/s11302-017-9592-1. Epub 2017 Nov 23.

20.

Palliative Care Communication in the ICU: Implications for an Oncology-Critical Care Nursing Partnership.

Boyle DA, Barbour S, Anderson W, Noort J, Grywalski M, Myer J, Hermann H.

Semin Oncol Nurs. 2017 Dec;33(5):544-554. doi: 10.1016/j.soncn.2017.10.003. Epub 2017 Oct 26. Review.

PMID:
29107532
21.

The population-level costs of immunosuppression medications for the treatment of glomerulonephritis are increasing over time due to changing patterns of practice.

Barbour S, Lo C, Espino-Hernandez G, Sajjadi S, Feehally J, Klarenbach S, Gill J.

Nephrol Dial Transplant. 2018 Apr 1;33(4):626-634. doi: 10.1093/ndt/gfx185.

PMID:
29106654
22.

Palliative Care Professional Development for Critical Care Nurses: A Multicenter Program.

Anderson WG, Puntillo K, Cimino J, Noort J, Pearson D, Boyle D, Grywalski M, Meyer J, O'Neil-Page E, Cain J, Herman H, Barbour S, Turner K, Moore E, Liao S, Ferrell B, Mitchell W, Edmonds K, Fairman N, Joseph D, MacMillan J, Milic MM, Miller M, Nakagawa L, O'Riordan DL, Pietras C, Thornberry K, Pantilat SZ.

Am J Crit Care. 2017 Sep;26(5):361-371. doi: 10.4037/ajcc2017336.

23.

Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.

Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, Monaghan H, Zhao M, Barbour S, Reich H, Cattran D, Glassock R, Levin A, Wheeler D, Woodward M, Billot L, Chan TM, Liu ZH, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Wang HY, Perkovic V; TESTING Study Group.

JAMA. 2017 Aug 1;318(5):432-442. doi: 10.1001/jama.2017.9362.

24.

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.

Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, Danso MA, Dennis K, Dupuis LL, Dusetzina SB, Eng C, Feyer PC, Jordan K, Noonan K, Sparacio D, Somerfield MR, Lyman GH.

J Clin Oncol. 2017 Oct 1;35(28):3240-3261. doi: 10.1200/JCO.2017.74.4789. Epub 2017 Jul 31. Review.

PMID:
28759346
25.

Patterns of care for ductal carcinoma in situ of the breast: Queensland's experience over a decade.

Barbour S, Moore J, Dunn N, Effeney R, Harden H, McCarthy A, Walpole E, Lehman M.

Breast. 2017 Oct;35:169-176. doi: 10.1016/j.breast.2017.07.003.

26.

Nitrate release from waste rock dumps in the Elk Valley, British Columbia, Canada.

Mahmood FN, Barbour SL, Kennedy C, Hendry MJ.

Sci Total Environ. 2017 Dec 15;605-606:915-928. doi: 10.1016/j.scitotenv.2017.05.253. Epub 2017 Jul 6.

PMID:
28693108
27.

Fate and Transport of Shale-derived, Biogenic Methane.

Hendry MJ, Schmeling EE, Barbour SL, Huang M, Mundle SOC.

Sci Rep. 2017 Jul 7;7(1):4881. doi: 10.1038/s41598-017-05103-8.

28.

NCCN Guidelines Insights: Antiemesis, Version 2.2017.

Berger MJ, Ettinger DS, Aston J, Barbour S, Bergsbaken J, Bierman PJ, Brandt D, Dolan DE, Ellis G, Kim EJ, Kirkegaard S, Kloth DD, Lagman R, Lim D, Loprinzi C, Ma CX, Maurer V, Michaud LB, Nabell LM, Noonan K, Roeland E, Rugo HS, Schwartzberg LS, Scullion B, Timoney J, Todaro B, Urba SG, Shead DA, Hughes M.

J Natl Compr Canc Netw. 2017 Jul;15(7):883-893. doi: 10.6004/jnccn.2017.0117.

PMID:
28687576
29.

A spatial framework for targeting urban planning for pollinators and people with local stakeholders: A route to healthy, blossoming communities?

Bellamy CC, van der Jagt APN, Barbour S, Smith M, Moseley D.

Environ Res. 2017 Oct;158:255-268. doi: 10.1016/j.envres.2017.06.023. Epub 2017 Jun 26.

PMID:
28662451
30.

Estimates of water and solute release from a coal waste rock dump in the Elk Valley, British Columbia, Canada.

Villeneuve SA, Barbour SL, Hendry MJ, Carey SK.

Sci Total Environ. 2017 Dec 1;601-602:543-555. doi: 10.1016/j.scitotenv.2017.05.040. Epub 2017 May 31.

PMID:
28575832
31.

An update on the treatment of IgA nephropathy.

Barbour S, Feehally J.

Curr Opin Nephrol Hypertens. 2017 Jul;26(4):319-326. doi: 10.1097/MNH.0000000000000336. Review.

PMID:
28399021
32.

Management of Patients With Chemotherapy-Induced Nausea and Vomiting.

Barbour SY.

J Adv Pract Oncol. 2017 Apr;8(3):303-308. Epub 2017 Apr 1. Review.

33.

Integrated safety analysis of rolapitant with coadministered drugs from phase II/III trials: an assessment of CYP2D6 or BCRP inhibition by rolapitant.

Barbour S, Smit T, Wang X, Powers D, Arora S, Kansra V, Aapro M, Herrstedt J.

Ann Oncol. 2017 Jun 1;28(6):1268-1273. doi: 10.1093/annonc/mdx073.

34.

Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort study.

Hutton HL, Levin A, Gill J, Djurdjev O, Tang M, Barbour SJ.

BMC Nephrol. 2017 Mar 20;18(1):95. doi: 10.1186/s12882-017-0511-z.

35.

Analyses of Calcium-Independent Phospholipase A2beta (iPLA2β) in Biological Systems.

Barbour SE, Ramanadham S.

Methods Enzymol. 2017;583:119-141. doi: 10.1016/bs.mie.2016.09.001. Epub 2016 Oct 18.

36.

Frequently relapsing anti-glomerular basement membrane antibody disease with changing clinical phenotype and antibody characteristics over time.

Gu B, Magil AB, Barbour SJ.

Clin Kidney J. 2016 Oct;9(5):661-4. doi: 10.1093/ckj/sfw048. Epub 2016 Jun 19.

37.

Measuring Concentrations of Dissolved Methane and Ethane and the 13 C of Methane in Shale and Till.

Hendry MJ, Barbour SL, Schmeling EE, Mundle SO.

Ground Water. 2017 Jan;55(1):119-128. doi: 10.1111/gwat.12445. Epub 2016 Aug 1.

PMID:
27479633
38.

Recognizing IgG4-related tubulointerstitial nephritis.

Mann S, Seidman MA, Barbour SJ, Levin A, Carruthers M, Chen LY.

Can J Kidney Health Dis. 2016 Jul 17;3:34. doi: 10.1186/s40697-016-0126-5. eCollection 2016. Review.

39.

Strict Regiospecificity of Human Epithelial 15-Lipoxygenase-2 Delineates Its Transcellular Synthesis Potential.

Green AR, Barbour S, Horn T, Carlos J, Raskatov JA, Holman TR.

Biochemistry. 2016 May 24;55(20):2832-40. doi: 10.1021/acs.biochem.5b01339. Epub 2016 May 13.

40.

Characterization of physical mass transport through oil sands fluid fine tailings in an end pit lake: a multi-tracer study.

Dompierre KA, Barbour SL.

J Contam Hydrol. 2016 Jun;189:12-26. doi: 10.1016/j.jconhyd.2016.03.006. Epub 2016 Mar 29.

PMID:
27061245
41.

Board-Certified Oncology Pharmacists: Their Potential Contribution to Reducing a Shortfall in Oncology Patient Visits.

Ignoffo R, Knapp K, Barnett M, Barbour SY, D'Amato S, Iacovelli L, Knudsen J, Koontz SE, Mancini R, McBride A, McCauley D, Medina P, O'Bryant CL, Scarpace S, Stricker S, Trovato JA.

J Oncol Pract. 2016 Apr;12(4):e359-68. doi: 10.1200/JOP.2015.008490. Epub 2016 Mar 22.

PMID:
27006358
42.

The MEST score provides earlier risk prediction in lgA nephropathy.

Barbour SJ, Espino-Hernandez G, Reich HN, Coppo R, Roberts IS, Feehally J, Herzenberg AM, Cattran DC; Oxford Derivation, North American Validation and VALIGA Consortia; Oxford Derivation North American Validation and VALIGA Consortia.

Kidney Int. 2016 Jan;89(1):167-75. doi: 10.1038/ki.2015.322.

PMID:
26759049
43.

Safety and tolerability of eribulin mesylate in patients with pretreated metastatic breast cancer.

Goodin S, Barbour S, Song J, Berrak E, Cox D.

Am J Health Syst Pharm. 2015 Dec 15;72(24):2150-6. doi: 10.2146/ajhp140773.

PMID:
26637514
44.

Defining near-surface groundwater flow regimes in the semi-arid glaciated plains of North America.

Hendry MJ, Barbour SL, Schmeling EE.

Isotopes Environ Health Stud. 2016 Jun;52(3):203-13. doi: 10.1080/10256016.2016.1092966. Epub 2015 Nov 25.

PMID:
26606976
45.

ICU Bedside Nurses' Involvement in Palliative Care Communication: A Multicenter Survey.

Anderson WG, Puntillo K, Boyle D, Barbour S, Turner K, Cimino J, Moore E, Noort J, MacMillan J, Pearson D, Grywalski M, Liao S, Ferrell B, Meyer J, O'Neil-Page E, Cain J, Herman H, Mitchell W, Pantilat S.

J Pain Symptom Manage. 2016 Mar;51(3):589-596.e2. doi: 10.1016/j.jpainsymman.2015.11.003. Epub 2015 Nov 18.

PMID:
26596882
46.

Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis.

Barbour SJ, Cattran DC, Espino-Hernandez G, Hladunewich MA, Reich HN.

Kidney Int. 2015 Dec;88(6):1392-1401. doi: 10.1038/ki.2015.241. Epub 2015 Aug 19.

PMID:
26287314
47.

Effect of high fat diet on paternal sperm histone distribution and male offspring liver gene expression.

Terashima M, Barbour S, Ren J, Yu W, Han Y, Muegge K.

Epigenetics. 2015;10(9):861-71. doi: 10.1080/15592294.2015.1075691.

48.

A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).

Fervenza FC, Canetta PA, Barbour SJ, Lafayette RA, Rovin BH, Aslam N, Hladunewich MA, Irazabal MV, Sethi S, Gipson DS, Reich HN, Brenchley P, Kretzler M, Radhakrishnan J, Hebert LA, Gipson PE, Thomas LF, McCarthy ET, Appel GB, Jefferson JA, Eirin A, Lieske JC, Hogan MC, Greene EL, Dillon JJ, Leung N, Sedor JR, Rizk DV, Blumenthal SS, Lasic LB, Juncos LA, Green DF, Simon J, Sussman AN, Philibert D, Cattran DC; Mentor Consortium group.

Nephron. 2015;130(3):159-68. doi: 10.1159/000430849. Epub 2015 Jun 12.

PMID:
26087670
49.

Reservoirs of Selenium in Coal Waste Rock: Elk Valley, British Columbia, Canada.

Hendry MJ, Biswas A, Essilfie-Dughan J, Chen N, Day SJ, Barbour SL.

Environ Sci Technol. 2015 Jul 7;49(13):8228-36. doi: 10.1021/acs.est.5b01246. Epub 2015 Jun 15.

PMID:
26038975
50.

The need for improved uptake of the KDIGO glomerulonephritis guidelines into clinical practice in Canada: a survey of nephrologists.

Barbour S, Beaulieu M, Gill J, Espino-Hernandez G, Reich HN, Levin A.

Clin Kidney J. 2014 Dec;7(6):538-45. doi: 10.1093/ckj/sfu104. Epub 2014 Oct 24.

Supplemental Content

Loading ...
Support Center